|Articles|November 29, 2011

Nelson Labs to Address Cleaning Validations at BIOMEDevice Show

Nelson Laboratories Michael Neilson, BS, RM(NRCM), will present three topics to medical device manufacturers attending the 2011 BIOMEDevice Exposition and Conference in San Jose, Dec. 6-7, 2011 at exhibit booth #1120. Topics will include test trends for hemocompatibility, how to avoid contamination for newly manufactured devices and recent trends from the Food and Drug Administration (FDA) regarding reusable device cleaning validations.

Neilson will be at the Innovation Briefs Theater, exhibit booth #801, to conduct a Cleaning Evaluation Validations and Recent FDA Trends presentation on December 7 at 12:30 p.m.

Each time Nelson Laboratories presents a topic, it is with the goal that manufacturers will be able to save time and money, says Jeffery R. Nelson, president and CEO of Nelson Laboratories. It is imperative manufacturers understand the reusable device validation process in order to prevent delays with their FDA submissions and ensuring timely release of new products.

Neilson is Nelson Labs' hospital reprocessing section leader,  who specializes in cleaning, disinfection and sterilization of reusable medical devices. As section leader, he is responsible for managing personnel, resources and business strategies for reprocessing validations that are performed at Nelson Labs.

Nelson Labs will conduct the 10-minute presentations at booth #1120. The presentations include:

- Cleaning Evaluation Validations and Recent FDA Trends
December 6, 10:30 a.m., 1:30 p.m. and December 7, 10:30 a.m., 1:30 p.m.

- FDA Test Trends for Hemocompatibility
December 6, 11:30 a.m., 2:30 p.m. and December 7, 11:30 a.m., 2:30 p.m.

- Cleaning Validations for Newly Manufactured Devices
December 6, 12:30 p.m., 3:30 p.m. and December 7, 3:30 p.m.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.